On Monday, Skye Bioscience Inc (NASDAQ: SKYE) opened lower -60.00% from the last session, before settling in for the closing price of $4.75. Price fluctuations for SKYE have ranged from $1.14 to $5.96 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 42.99%. Company’s average yearly earnings per share was noted -92.81% at the time writing. With a float of $18.10 million, this company’s outstanding shares have now reached $30.99 million.
Skye Bioscience Inc (SKYE) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Skye Bioscience Inc is 41.59%, while institutional ownership is 27.40%. The most recent insider transaction that took place on Aug 22 ’25, was worth 582,936. In this transaction Director of this company sold 170,449 shares at a rate of $3.42, taking the stock ownership to the 57,493 shares. Before that another transaction happened on Aug 21 ’25, when Company’s Director sold 60,956 for $3.57, making the entire transaction worth $217,613. This insider now owns 63,963 shares in total.
Skye Bioscience Inc (SKYE) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.1 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.25) by 0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -92.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -22.03% during the next five years compared to 42.99% growth over the previous five years of trading.
Skye Bioscience Inc (NASDAQ: SKYE) Trading Performance Indicators
Check out the current performance indicators for Skye Bioscience Inc (SKYE). In the past quarter, the stock posted a quick ratio of 6.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.07, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -1.22 in one year’s time.
Technical Analysis of Skye Bioscience Inc (SKYE)
Looking closely at Skye Bioscience Inc (NASDAQ: SKYE), its last 5-days average volume was 3.65 million, which is a jump from its year-to-date volume of 0.7 million. As of the previous 9 days, the stock’s Stochastic %D was 60.90%.
During the past 100 days, Skye Bioscience Inc’s (SKYE) raw stochastic average was set at 3.27%, which indicates a significant decrease from 4.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.35 in the past 14 days, which was higher than the 0.35 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.70, while its 200-day Moving Average is $2.88. However, in the short run, Skye Bioscience Inc’s stock first resistance to watch stands at $2.21. Second resistance stands at $2.52. The third major resistance level sits at $2.74. If the price goes on to break the first support level at $1.68, it is likely to go to the next support level at $1.46. Should the price break the second support level, the third support level stands at $1.15.
Skye Bioscience Inc (NASDAQ: SKYE) Key Stats
There are currently 30,988K shares outstanding in the company with a market cap of 58.88 million. Presently, the company’s annual sales total 0 K according to its annual income of -26,570 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -17,620 K.
